Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

0

539680

GANGAPHARM

img img img img
No Data Available

Ganga Pharmaceuticals Limited Share Price Update

As of the latest trading session, Ganga Pharmaceuticals Limited share price is currently at ₹ 11.8, which is up by ₹ 0.00 from its previous closing. Today, the stock has fluctuated between ₹ 9.35 and ₹ 11.80. Over the past year, Ganga Pharmaceuticals Limited has achieved a return of -35.11 %. In the last month alone, the return has been [-] %. Read More...

Investment Returns

Over 1 Month 0.00% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Ganga Pharmaceuticals Limited fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    7.00

  • P/E Ratio (TTM)

    90.77

  • Beta

    1.85

  • Book Value / share

    13.55

  • Return on equity

    1.13%

  • EPS (TTM)

    0.13

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.00

info icon alternate text

Ganga Pharmaceuticals Limited Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.00
Net Profit 0.00
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.00
EBITDA 0.00
Effective Tax Rate (%) 0.00
Particulars MAR 2025 (Values in Cr)
Revenue 2.64
Operating Expense 2.98
Net Profit 0.08
Net Profit Margin (%) 3.03
Earnings Per Share (EPS) 0.16
EBITDA 0.32
Effective Tax Rate (%) 22.22
Particulars MAR 2024 (Values in Cr)
Revenue 2.74
Operating Expense 2.91
Net Profit 0.05
Net Profit Margin (%) 1.82
Earnings Per Share (EPS) 0.11
EBITDA 0.29
Effective Tax Rate (%) 33.33
Particulars MAR 2023 (Values in Cr)
Revenue 2.59
Operating Expense 2.83
Net Profit 0.04
Net Profit Margin (%) 1.54
Earnings Per Share (EPS) 0.10
EBITDA 0.30
Effective Tax Rate (%) 20.00
Particulars MAR 2022 (Values in Cr)
Revenue 2.49
Operating Expense 2.69
Net Profit 0.04
Net Profit Margin (%) 1.60
Earnings Per Share (EPS) 0.09
EBITDA 0.29
Effective Tax Rate (%) 20.00
Particulars MAR 2021 (Values in Cr)
Revenue 2.37
Operating Expense 2.59
Net Profit 0.02
Net Profit Margin (%) 0.84
Earnings Per Share (EPS) 0.05
EBITDA 0.28
Effective Tax Rate (%) 50.00
Particulars MAR 2025 (Values in Cr)
Book Value / Share 13.46
ROE % 1.13
ROCE % 3.30
Total Debt to Total Equity 0.20
EBITDA Margin 12.12
Particulars MAR 2024 (Values in Cr)
Book Value / Share 13.30
ROE % 0.80
ROCE % 3.18
Total Debt to Total Equity 0.25
EBITDA Margin 10.58
Particulars MAR 2023 (Values in Cr)
Book Value / Share 13.42
ROE % 0.74
ROCE % 3.28
Total Debt to Total Equity 0.35
EBITDA Margin 11.58
Particulars MAR 2022 (Values in Cr)
Book Value / Share 13.32
ROE % 0.74
ROCE % 3.32
Total Debt to Total Equity 0.34
EBITDA Margin 12.05
Particulars MAR 2021 (Values in Cr)
Book Value / Share 13.23
ROE % 0.37
ROCE % 3.30
Total Debt to Total Equity 0.30
EBITDA Margin 11.81
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.30
Total Assets 8.97
Total Liabilities 8.97
Total Equity 7.13
Share Outstanding 4836500
Price to Book Ratio 0.76
Return on Assets (%) 0.88
Return on Capital (%) 0.92
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 8.64
Total Liabilities 8.64
Total Equity 7.05
Share Outstanding 4836500
Price to Book Ratio 0.00
Return on Assets (%) 0.53
Return on Capital (%) 0.55
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.98
Total Liabilities 7.98
Total Equity 5.45
Share Outstanding 4061500
Price to Book Ratio 0.00
Return on Assets (%) 0.49
Return on Capital (%) 0.54
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.02
Total Assets 7.99
Total Liabilities 7.99
Total Equity 5.41
Share Outstanding 4061500
Price to Book Ratio 0.77
Return on Assets (%) 0.47
Return on Capital (%) 0.52
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 7.66
Total Liabilities 7.66
Total Equity 5.37
Share Outstanding 4061500
Price to Book Ratio 0.00
Return on Assets (%) 0.26
Return on Capital (%) 0.29
Particulars MAR 2025 (Values in Cr)
Net Income 0.09
Cash from Operations -0.56
Cash from Investing 1.18
Cash from Financing -0.33
Net change in Cash 0.27
Free Cash Flow -0.46
Particulars MAR 2024 (Values in Cr)
Net Income 0.06
Cash from Operations -1.24
Cash from Investing 0.12
Cash from Financing 1.13
Net change in Cash 0.00
Free Cash Flow -1.22
Particulars MAR 2023 (Values in Cr)
Net Income 0.05
Cash from Operations -0.02
Cash from Investing 0.49
Cash from Financing -0.44
Net change in Cash 0.00
Free Cash Flow 0.00
Particulars MAR 2022 (Values in Cr)
Net Income 0.05
Cash from Operations -0.19
Cash from Investing 0.18
Cash from Financing 0.02
Net change in Cash 0.00
Free Cash Flow -0.18
Particulars MAR 2021 (Values in Cr)
Net Income 0.03
Cash from Operations -0.16
Cash from Investing 0.27
Cash from Financing -0.09
Net change in Cash 0.00
Free Cash Flow -0.14
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.93 12.71 1.34 198.71 25.50 / 53.83
BLISS GVS PHARMA LTD 157.05 15.16 1.46 1661.42 105.05 / 195.85
CIPLA LTD 1377.85 20.46 3.38 111298.76 1310.05 / 1672.20
FERMENTA BIOTECH LIMITED 330.80 8.69 2.49 973.58 219.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2269.80 40.34 22.51 38451.78 1924.30 / 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 25.93 21.08 3.61 198.71 25.50 / 53.83
AMRUTAJAN HEALTH LTD 603.00 30.75 5.09 1743.31 548.05 / 789.95
ASTRAZENECA PHARMA IND LT 8249.70 89.21 25.81 20624.25 6501.60 / 10653.05
BLISS GVS PHARMA LTD 157.05 21.19 1.50 1661.42 105.05 / 195.85

Ganga Pharmaceuticals Limited shareholding pattern

Holding

49.08%
50.91%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Ganga Pharmaceuticals Limited Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
11.80 1.02 redarrow
red-green-graph indicator
1 Bearish
15 Bullish
  • 5 Days 12.70
  • 26 Days 14.50
  • 10 Days 12.90
  • 50 Days 15.70
  • 12 Days 13.00
  • 100 Days 15.10
  • 20 Days 13.90
  • 200 Days 12.20
11.68 PIVOT

First Support

11.68

First Resistance

11.68

Second Support

11.68

Second Resistance

11.68

Third Support

11.68

Third Resistance

11.68

RSI

38.01

ADX

63.60

MACD

0.00

Williams % R

-56.22

Commodity Channel Index (CCI)

-52.13

Date

2025-11-20

Week

8000.00

Same Day

8000.00

Month

8000.00

1 Year

1.85

3 Year

2.27

Over 1 Month

0.00%

down

Over 1 Year

-35.11%

down

Over 3 Months

-20.00%

down

Over 3 Years

0.11%

down

Over 6 Months

-21.08%

down

Over 5 Years

5.11%

down

Ganga Pharmaceuticals Limited Corporate Actions

Top Gainers

Ganga Pharmaceuticals Limited Share Price

Ganga Pharmaceuticals Ltd was incorporated as a Public Limited Company in Aug.'94 and promoted by Brij Mohan Sharma. he Company is engaged in the business of manufacturing & trading in Pharmaceuticals & allied products (Ayurveda).

In Apr.'95, the company took over Ganga pharmaceuticals, a proprietory concern (owned by the same promoter), which was manufacturing and marketing ayurvedic products since the last two decades.

The company which manufactures ayurvedic medicines, started commercial production in Apr.'95. In Jul.'96, it came out with a public issue to part-finance the expansion programme involving setting up of a new manufacturing unit for the manufacture of ayurvedic medicines at Murbad, Maharashtra.

The company which commenced exports in Jan.'96, has marketing arrangements with parties located in Saudi Arabia, Dubai, Italy, Romania and Russia to market its products in their respective regions.

Parent organization Indian Private
NSE symbol [-]
Founded 1989
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Ganga Pharmaceuticals Ltd?

Answer Field

Ganga Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 11.80 as on Jan 21 2026 12:00 AM.

What is the Market Cap of Ganga Pharmaceuticals Ltd Share?

Answer Field

The market cap of Ganga Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 7.00 as on Jan 21 2026 12:00 AM.

What is the 52 Week High and Low of Ganga Pharmaceuticals Ltd?

Answer Field

The 52 Week High and Low of Ganga Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 17.00 and ₹ 9.25.

What is 1 year return for Ganga Pharmaceuticals Ltd?

Answer Field

The 1 year returns on the stock has been -30.58%.

What is the P/E Ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Jan 21 2026 12:00 AM the price-to-earnings (PE) ratio for Ganga Pharmaceuticals Ltd share is 90.77.

What is the PB ratio of Ganga Pharmaceuticals Ltd Share?

Answer Field

As on Jan 21 2026 12:00 AM, the price-to-book (PB) ratio for Ganga Pharmaceuticals Ltd share is 13.55.

How to Buy Ganga Pharmaceuticals Ltd Share?

Answer Field

You can trade in Ganga Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Ganga Pharmaceuticals Ltd Share on Bajaj Broking App?

Answer Field

To buy Ganga Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Ganga Pharmaceuticals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59